Where does Sunshine Lake Pharma Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sunshine Lake Pharma Co., Ltd. ranks #3,460 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sunshine Lake Pharma Co., Ltd. hold?

Sunshine Lake Pharma Co., Ltd. holds 107 US utility patents granted between 2015 and 2025, spanning 22 technology areas.

What is Sunshine Lake Pharma Co., Ltd.'s Innovation Score?

Sunshine Lake Pharma Co., Ltd. has an Innovation Score of 47.1 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sunshine Lake Pharma Co., Ltd. focus on?

Sunshine Lake Pharma Co., Ltd.'s top technology area is C07D (Heterocyclic Compounds) with 95 patents, ranking #71 of 3,165 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

Is Sunshine Lake Pharma Co., Ltd.'s patent grant rate increasing or decreasing?

Sunshine Lake Pharma Co., Ltd.'s recent grant velocity is -47% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sunshine Lake Pharma Co., Ltd.'s patents?

Sunshine Lake Pharma Co., Ltd.'s patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sunshine Lake Pharma Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sunshine Lake Pharma Co., Ltd.

USPTO PatentsView assignee record - 107 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sunshine ranks #3,460 of 49,997 tracked US assignees by granted-patent volume, with 107 patents across 22 technology areas.

#3,460
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.1/100): 17.6
avg claims per patent: -47%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3460 · Foreign Corporation #3,460 · 107 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 107 grants
TOP-DECILE #3,460/49,997
PHOTO-FINISH Ohio University
CPC-FOCUS C07D · 22 areas
INNOV-PAR 47.1/100
CLAIMS-RICH 17.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -47% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ohio University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sunshine’s 47.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.2 pts (34%) Velocity 3.8 pts (8%) Breadth 16.6 pts (35%) Claim depth 10.5 pts (22%)

Qualcomm Incorporated · highest

85
Bnnt · near

47
Dentsply International · near

47
Omron Automotive · near

47
Sunshine Lake Pharma · this assignee

47
UV Partners · near

47
3D Lighting… · lowest

7

What this shows Sunshine's Innovation Score is 47.1/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sunshine?

Each dot is one of Sunshine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sunshine’s own 17.6 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sunshine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sunshine's grants concentrate

Sunshine Lake Pharma Co., Ltd. is a focused PatentsView assignee: 22 CPC subclasses with 88.8% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2017 (19 grants) versus a trough of 1 in 2023. By volume, Sunshine sits between Ohio University and WMS Gaming, Inc..

Sunshine's three-year grant acceleration

From 2019–2021 to 2022–2024, Sunshine Lake Pharma Co., Ltd. moved from 30 to 17 grants (0.57x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,534. See the growth leaderboard.

Ohio University

107
Persimmon

107
Reckitt Benckiser…

107
Sacmi Cooperativa…

107
THE Catholic Univ…

107
THE Conard Pyle

107
Vizio

107
WMS Gaming

107
Sunshine Lake Pha… ◀

107

What this shows Sunshine holds 107 patents at rank #3,460, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sunshine

By rank, the assignees closest to #3,460 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Sunshine's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sunshine, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Sunshine ranks #71 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Omron Automotive Electronics Co., Ltd. 47 Dentsply International Inc. 47 Bnnt, LLC 47 UV Partners, Inc. 47

Similar claim depth

Nearest assignees by average claims per patent (17.6 here).

Dali Systems Co. Ltd 17.6 avg Globalwafers Co., Ltd. 17.6 avg Vibrant Holdings, LLC 17.6 avg Boise State University 17.6 avg

Sunshine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sunshine Lake Pharma Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	5.6%
2016	17	15.9%
2017	19	17.8%
2018	12	11.2%
2019	12	11.2%
2020	6	5.6%
2021	12	11.2%
2022	12	11.2%
2023	1	0.9%
2024	4	3.7%
2025partial year	6	5.6%

Which technologies does Sunshine Lake Pharma Co., Ltd. patent most?

C07D - Heterocyclic Compounds 95

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 90

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 84

C07C - Acyclic OR Carbocyclic Compounds 10

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 7

Y02A - Technologies FOR Adaptation TO Climate Change 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C07K - Peptides 3

C03C - Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other Materials 2

F21V - Functional Features OR Details OF Lighting Devices OR Systems THEREOF; Structural Combinations OF Lighting Devices With Other Articles, NOT Otherwise Provided FOR 1

F21Y - Indexing Scheme Associated With Subclasses F21k, F21l, F21s and F21v, Relating TO THE Form OR THE Kind OF THE Light Sources OR OF THE Colour OF THE Light Emitted 1

A01M - Catching, Trapping OR Scaring OF Animals ; Apparatus FOR THE Destruction OF Noxious Animals OR Noxious Plants 1

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sunshine Lake Pharma Co., Ltd.'s patent record in context - here's where to go next.

Sunshine Lake Pharma Co., Ltd.'s lead technology class is C07D (Heterocyclic Compounds), 88.8% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #3,460 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sunshine Lake Pharma Co., Ltd. against Ohio University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.